In addition, in vivo and in vitro studies have found that statins, which are HMG-CoA reductase inhibitors used for the treatment of hyperlipidemia, may increase the susceptibility of myeloma cells to apoptosis through a variety of ways. This evidence concerns the gene HMGCR and plasma cell myeloma.